HIV & Fwens Flashcards
Gimme the regimen combi HBV coinfected regimen \+ PrEP PEP timelines
2 NRTI + NNRTI / II / PI + PK
- EI is not here
NRTI w HBV
- will have Emtri/Lami + TAF/TDF,
PrEP - Emtricitabine + Tenfovir - take for 1 week; then after contact 4 weeks PEP - standard RVT - take within 3 days, for 4 weeks
NRTI
MOA [3] - gimme enzyme
HBV which ones can and whats the problem
They are ribosides analogs wO 3’OH group
- enter cell, viral phosphorylase
- chain termination
- HSV: Viral thymidine kinase
- CMV: viral phosphotransferase
Tenofavir
Emitricitabine
Lamivudine all can
- problem is exacerbation of hepatitise in coinfected Px when remove drugs
NRTI
- ROA, ROE
- whats the deal w guanosine and adenosine analogs
Oral, Renal
- Guanosine: Abacavir (A) - HLA-B 5701 NEGATIVE
- Adenosine: Tenofovir - 2: TDF, TAF
- TAF better on renal markers, bone markers
Integrase Inhibitors
- names
- ROA, ROE
- whats the problem
Raltegravir; Dolutegravir
- Oral, Hepatic
- Cation problem
Protease inhibitor
- names
- ROA, ROE
- whats the problem
AE
Contra-I drug
navir
- Lopinavir, Darunavir
- Plus Ritonavir PK enhancer
Oral Hepatic
- CYP450 INHIBITOR
AE - HHH
- hyperglycaemia, hyperlipidaemia
- hepatotoxic
- lipodystrophy
Contra-I
- statins cos of CYP and hyperlipid
NNRTI
Efavirenz
- non-competitive inhibitor
- allosteric
ORAL, RENAL
- induce CYP
Entry inhibitor
- biochemistry
HIV
- GP120 binds to CD4 and CCR5
- then GP41 binds CD4 for entry
Enfuvirtide - subcutanous injection
- binds GP41 to block GP41-CD4
Maraviroc - oral
- binds CCR5 to block GP120-CCR5
- check CCR5 vs CXCR4 tropism’
Acyclovir
MOA
2 names
ROA, ROE
Guanosine analog
- enter cells, viral thymidine kinase phoshorylat
- chain termination
Acyclovir and Val-acyclovir
- val better oral bioabvailability cos ester
Oral, Renal
can IV also
Gancyclovir
MOA
2 names
ROA, ROE
Also guanosine analog
CMV: viral phosphotransferase; HSV also can
Val and normal
Oral, Renal
What does Efavirenz bind to
GP41
What does Maraviroc bind to
CCR5
What are side effects of Protease inhibitor
CYP Inhibition
- GI
- Hepatotoxicity
- Hyperlipidemia, Hyperglycemia